Asian Pacific Journal of Cancer Prevention · 2014 · 31 citations · 9 references
MedicineCancer BiologyOncologyBreast OncologyChemotherapyMolecular OncologyBreast Cancer OncologyCancer BiomarkersCancer Molecular PathologyLocally Advanced Breast CancerAnticancer ChemotherapyBreast Cancer PrognosisBreast Cancer Response AssessmentNf-kappa B-mediated Anti-apoptotic SignalingNf-κb SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B SignalingPositive Predictive Value
BACKGROUND: NF-κB inhibits apoptosis through induction of antiapoptotic proteins and suppression of proapoptotic genes. Various chemotherapy agents induce NF-κB translocation and target gene activation. We conducted the present study to assess the predictive value of NF-κB regarding pathologic responses after receiving neoadjuvant chemotherapy. MATERIALS AND METHODS: We enrolled 131 patients with locally advanced invasive ductal breast carcinoma. Immunohistochemistry (IHC) was used to detect NF-κB expression. Evaluation of pathologic response was elaborated with the Ribero classification. RESULTS: Expression of NF-κB was significantly associated with poor pathological response (p=0.02). From the multivariate analysis, it was found that the positive expression of NF-κB yielded RR=1.74 (95%CI 0.77 to 3.94). CONCLUSIONS: NF-κB can be used as a predictor of poor pathological response after neoadjuvant chemotherapy.
9
Stanley He, Zhihui Liu, Doo‐Yi Oh et al. · Frontiers in Oncology · 2013 · 329 citations · Full text
Life Sciences, Genetics, Oncology +17
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
P. Godwin, Anne‐Marie Baird, Susan Heavey et al. · Frontiers in Oncology · 2013 · 305 citations · Full text
Medicine, Oncology, Pharmacology +16
Ana M. González-Angulo, Sean E. McGuire, Thomas A. Buchholz et al. · Journal of Clinical Oncology · 2005 · 111 citations · Full text